Xbrane Biopharma AB (publ) (XBRANE.ST)

SEK 0.16

(-3.53%)

Annual Balance Sheets

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 653.5 Million 690.51 Million 688.42 Million 463.76 Million 338.94 Million 252.88 Million
Total Current Assets 461.69 Million 513.52 Million 561 Million 374.48 Million 247.93 Million 161.65 Million
Cash And Short Term Investments 65.4 Million 193.99 Million 295.18 Million 243.13 Million 164.19 Million 100.97 Million
Cash and Cash Equivalents 65.4 Million 193.99 Million 295.18 Million 243.13 Million 164.19 Million 100.97 Million
Short Term Investments - - - - - -
Net Receivables 71.17 Million 47.45 Million 50.25 Million 58.36 Million 5.88 Million 10.48 Million
Inventory 106.85 Million 50.26 Million 215.57 Million - - 5.52 Million
Other Current Assets 218.25 Million 221.81 Million 2000.00 72.97 Million 77.85 Million 55.16 Million
Total Non-Current Assets 191.81 Million 176.99 Million 127.41 Million 89.28 Million 91 Million 91.22 Million
Net PPE 88.2 Million 70.78 Million 73.8 Million 14.13 Million 16.2 Million 16.74 Million
Good Will And Intangible Assets 99.67 Million 101.99 Million 49.67 Million 62.53 Million 65.81 Million 65.61 Million
Good Will - - - 58.45 Million 60.76 Million 59.83 Million
Intangible Assets 99.67 Million 101.99 Million 49.67 Million 4.08 Million 5.05 Million 5.77 Million
Long-Term Investments 3.94 Million 3.94 Million 3.94 Million 12.61 Million 8.98 Million 8.87 Million
Tax Assets -99.67 Million -3.94 Million -3.94 Million -12.61 Million -8.98 Million -8.87 Million
Other Non Current Assets 99.67 Million 4.21 Million 3.94 Million 12.61 Million 8.98 Million 8.87 Million
Other Assets - 1000.00 1000.00 - - -
Total Liabilities 482.17 Million 265.62 Million 256.68 Million 206.05 Million 154.61 Million 169.81 Million
Total Current Liabilities 326.55 Million 236.56 Million 219.66 Million 188.99 Million 139.61 Million 161.38 Million
Account Payables 30.97 Million 23.29 Million 41.39 Million 29.54 Million 21.09 Million 30.9 Million
Tax Payables 2.49 Million 2.18 Million 1.77 Million 1.32 Million 1.11 Million 123 Thousand
Short Term Debt 75.87 Million 9.16 Million 7.9 Million 2.26 Million 3.15 Million 45.56 Million
Deferred Revenue - 136.06 Million 74.97 Million 52.44 Million 30.18 Million 123 Thousand
Other Current Liabilities 219.71 Million 68.04 Million 95.39 Million 104.74 Million 85.17 Million 84.78 Million
Total Non Current Liabilities 155.61 Million 29.05 Million 37.01 Million 17.06 Million 15 Million 8.43 Million
Long-Term Debt 112.89 Million 29.05 Million 36.47 Million 3.99 Million 6.28 Million 4.15 Million
Deferred Revenue Non Current - - - 8.25 Million 4.17 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 42.71 Million - 543 Thousand 13.06 Million 8.72 Million 4.27 Million
Other Liabilities - - - - - -
Total Equity 171.33 Million 424.88 Million 431.74 Million 257.7 Million 184.32 Million 83.07 Million
Stock Holders Equity 171.33 Million 424.88 Million 431.74 Million 257.7 Million 184.32 Million 83.07 Million
Common Stock 6.68 Million 6.16 Million 5.61 Million 4.97 Million 3.45 Million 1.41 Million
Retained Earnings -1.27 Billion -885.82 Million -713.31 Million -524.93 Million -273.94 Million -107.9 Million
Accumulated other comprehensive income 10.12 Million 10.32 Million 5.16 Million 3.94 Million 6.71 Million 5.54 Million
Common Stock Equity 171.33 Million 424.88 Million 431.74 Million 257.7 Million 184.32 Million 83.07 Million
Capital Lease Obligation 42.71 Million 38.22 Million 44.38 Million 6.26 Million 9.42 Million 451 Thousand
Total Investments 3.94 Million 3.94 Million 3.94 Million 12.61 Million 8.98 Million 8.87 Million
Total Debt 231.47 Million 38.22 Million 44.38 Million 6.26 Million 9.43 Million 49.72 Million
Net Debt 166.07 Million -155.77 Million -250.79 Million -236.87 Million -154.76 Million -51.25 Million

Balance Sheet Charts